FNYS
ATRC icon

First New York Securities’s AtriCure ATRC Stock Holding History

First New York Securities’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-6,000
Closed -$66K – 282
2013
Q3 		$66K Buy
+6,000
New +$59.1K 0.03% 263

Other funds holding ATRC

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First New York Securities's ATRC Position: Q4 2013 in Review

First New York Securities sold out of AtriCure (ATRC) in Q4 2013, closing a stake of 6,000 shares — an estimated $66K sold.

First New York Securities first reported a position in ATRC in Q3 2013 and held it in 1 quarter. The position peaked at $66K in Q3 2013. 86 funds tracked by Wall St. Rank hold ATRC as of Q4 2013.

  • First New York Securities reported no remaining AtriCure position as of Q4 2013 after selling out during the quarter.
  • First New York Securities sold 6,000 AtriCure shares in Q4 2013, an estimated $66K.
  • First New York Securities first reported a position in AtriCure in Q3 2013 and held it in 1 quarter.
  • First New York Securities's AtriCure position peaked at $66K in Q3 2013.
  • 86 funds tracked by Wall St. Rank held AtriCure as of Q4 2013.

Based on First New York Securities's 13F filing for Q4 2013, filed 12 Feb 2014.